For instance, EAG1 is normally expressed in the brain and peripheral ganglia [1]–[3] and is transiently expressed in undifferentiated myoblasts [4] but it is aberrantly expressed in many tumor cells, where it might be a useful cancer marker and even a potential therapeutic target [5]–[7]. This evidence concerns the gene KCNH1 and cancer.